Literature DB >> 10491299

The human luteinizing hormone receptor gene promoter: activation by Sp1 and Sp3 and inhibitory regulation.

Y Geng1, C H Tsai-Morris, Y Zhang, M L Dufau.   

Abstract

To understand the transcriptional mechanism(s) of human LH receptor (LHR) gene expression, we have identified the dominant functional cis-elements that regulate the activity of the promoter domain (-1 to -176 bp from ATG). Mutagenesis demonstrated that the promoter activity was dependent on two Sp1 domains (-79 bp, -120 bp) in a transformed normal placental cell (PLC) and the choriocarcinoma JAR cell. Both elements interacted with endogenous Sp1 and Sp3 factors but not with Sp2 or Sp4. In Drosophila SL2 cells, the promoter was activated by either Sp1 or Sp3. An ERE half-site (EREhs) at -174 bp was inhibitory (by 100%), but was unresponsive to estradiol and did not bind the estrogen receptor or orphan receptors ERR1 and SF-1. The 5' upstream sequence (-177 to -2056 bp) inhibited promoter activity in PLC by 60%, but only minimally in JAR cells. Activation of the human LHR promoter through Sp1/3 factors is negatively regulated through EREhs and upstream sequences to exert control of gene expression. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10491299     DOI: 10.1006/bbrc.1999.1374

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Analysis of human Ki-67 gene promoter and identification of the Sp1 binding sites for Ki-67 transcription.

Authors:  Dong-Sheng Pei; Guo-Wei Qian; Hui Tian; Jie Mou; Wang Li; Jun-Nian Zheng
Journal:  Tumour Biol       Date:  2011-11-29

2.  Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene.

Authors:  Ying Zhang; Mingjuan Liao; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

3.  Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.

Authors:  Ying Zhang; Naheed Fatima; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 4.  Current concepts of follicle-stimulating hormone receptor gene regulation.

Authors:  Jitu W George; Elizabeth A Dille; Leslie L Heckert
Journal:  Biol Reprod       Date:  2010-08-25       Impact factor: 4.285

5.  Coactivator function of positive cofactor 4 (PC4) in Sp1-directed luteinizing hormone receptor (LHR) gene transcription.

Authors:  Mingjuan Liao; Ying Zhang; Jung-Hoon Kang; Maria L Dufau
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

Review 6.  Regulation of human luteinizing hormone receptor in the ovary.

Authors:  Takashi Minegishi; Kazuto Nakamura; Soichi Yamashita; Sadatomo Ikeda; Kayoko Kogure
Journal:  Reprod Med Biol       Date:  2008-02-01

7.  Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB.

Authors:  Ying Zhang; Maria L Dufau
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  17beta-Estradiol utilizes the estrogen receptor to regulate CD16 expression in monocytes.

Authors:  P R Kramer; V Winger; S F Kramer
Journal:  Mol Cell Endocrinol       Date:  2007-09-04       Impact factor: 4.102

9.  Unlocking repression of the human luteinizing hormone receptor gene by trichostatin A-induced cell-specific phosphatase release.

Authors:  Ying Zhang; Mingjuan Liao; Maria L Dufau
Journal:  J Biol Chem       Date:  2008-07-02       Impact factor: 5.157

10.  Protein kinase Calpha-induced derepression of the human luteinizing hormone receptor gene transcription through ERK-mediated release of HDAC1/Sin3A repressor complex from Sp1 sites.

Authors:  Mingjuan Liao; Ying Zhang; Maria L Dufau
Journal:  Mol Endocrinol       Date:  2008-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.